1. Sontheimer-Phelps, A.; Hassell, B.A.; Ingber, D.E. Modelling cancer in microfluidic human organs-on-chips. Nat. Rev. Cancer 2019, 19, 65–81, doi: 10.1038/s41568-018-0104-6.
2. Luai, R.Z.; Anand, S.; Billingsley, K.G.; Bisson, W.H.; Cercek, A.; Clarke, M.F.; Coussens, L.M.; Gast, C.E.; Geltzeiler, C.B.; Hansen, L.; et al. Colorectal cancer liver metastasis: evolving paradigms and future directions. Cell Mol. Gastroenterol. Hepatol. 2017, 3, 163–173, doi: 10.1016/j.jcmgh.2017.01.006.
3. Ferrara, N.; Hillan, K.J.; Novotny, W. Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy. Biochem. Biophys. Res. Commun. 2005, 333, 328–335, doi: 10.1016/j.bbrc.2005.05.132
4. Pavlidis, E.T.; Pavlidis, T.E. Role of bevacizumab in colorectal cancer growth and its adverse effects: a review. World J. Gastroenterol. 2013, 19, 5051–5060, doi: 10.3748/wjg.v19.i31.5051
5. Deok-Hoon, K.; Kim, M.R.; Jang, J.H.; Na, H.J.; Lee, S. A Review of anti-angiogenic targets for monoclonal antibody cancer therapy. Int. J. Mol. Sci. 2017, 18, 1786, doi: 10.3390/ijms18081786.
6. Reymond, N.; d'Água, B.B.; Ridley, A.J. Crossing the endothelial barrier during metastasis. Nat. Rev. Cancer 2013, 13, 858–870, doi: 10.1038/nrc3628.
7. Shenoy, A.K.; Lu, J. Cancer cells remodel themselves and vasculature to overcome the endothelial barrier. Cancer Lett. 2016, 380, 534–544, doi: 10.1016/j.canlet.2014.10.031
8. Kikuchi, S.; Yoshioka, Y.; Prieto-Vila, M.; Ochiya, T. Involvement of extracellular vesicles in vascular-related functions in cancer progression and metastasis. Int. J. Mol. Sci. 2019, 20, 2584, doi: 10.3390/ijms20102584.
9. Kalluri, R. The biology and function of fibroblasts in cancer. Nat. Rev. Cancer 2016, 16, 582–598, doi: 10.1038/nrc.2016.73.
10. Di Modugno, F.; Colosi, C.; Trono, P.; Antonacci, G.; Ruocco, G.; Nisticò, P. 3D models in the new era of immune oncology: focus on T cells, CAF and ECM. J. Exp. Clin. Cancer Res. 2019, 38, 117, doi: 10.1186/s13046- 019-1086-2.
11. Roma-Rodrigues, C.; Mendes, R.; Baptista, P.V.; Fernandes, A.R. Targeting tumor microenvironment for cancer therapy. Int. J. Mol. Sci. 2019, 20, 840, doi: 10.3390/ijms20040840.
12. Kahlert, C.; Kalluri, R. Exosomes in tumor microenvironment influence cancer progression and metastasis. J. Mol. Med. 2013, 91, 431–437, doi: 10.1007/s00109-013-1020-6.
13. Naito, Y.; Yoshioka, Y.; Yamamoto, Y.; Ochiya, T. How cancer cells dictate their microenvironment: present roles of extracellular vesicles. Cell Mol. Life Sci. 2017, 74, 697–713, doi: 10.1007/s00018-016-2346-3.
14. Hoarau-Véchot, J.; Rafii, A.; Touboul, C.; Pasquier, J. Halfway between 2D and animal models: are 3D cultures the ideal tool to study cancer-microenvironment interactions? Int. J. Mol. Sci. 2018, 19, 181, doi: 10.3390/ijms19010181.
15. Yamada, K.M.; Cukierman, E. Modeling tissue morphogenesis and cancer in 3D. Cell 2007, 130, 601–610, doi: 10.1016/j.cell.2007.08.006
16. Blaha, L.; Zhang, C.; Cabodi, M.; Wong, J.Y. A microfluidic platform for modeling metastatic cancer cell matrix invasion. Biofabrication 2017, 9, 045001, doi: 10.1088/1758-5090/aa869d.
17. Cheluvappa, R.; Scowen, P.; Eri, R. Ethics of animal research in human disease remediation, its institutional teaching; and alternatives to animal experimentation. Pharmacol. Res. Perspect. 2017, 5, e00332, doi: 10.1002/prp2.332.
18. Ravi, M.; Ramesh, A.; Pattabhi, A. Contributions of 3D cell cultures for cancer research. J. Cell Physiol. 2017, 232, 2679–2697, doi: 10.1002/jcp.25664.
19. Weeber, F.; Ooft, S.N.; Dijkstra, K.K.; Voest, E.E. Tumor organoids as a pre-clinical cancer model for drug discovery. Cell Chem. Biol. 2017, 24, 1092–1100, doi: 10.1016/j.chembiol.2017.06.012.
20. Jeon, J.S.; Bersini, S.; Gilardi, M.; Dubini, G.; Charest, J.L.; Moretti, M.; Kamm, R.D. Human 3d vascularized organotypic microfluidic assays to study breast cancer cell extravasation. Proc. Natl. Acad. Sci. USA 2015, 112, 214–219, doi: 10.1073/pnas.1417115112.
21. Chen, M.B.; Whisler, J.A.; Fröse, J.; Yu, C.; Shin, Y.; Kamm, R.D. On-chip human microvasculature assay for visualization and quantification of tumor cell extravasation dynamics. Nat. Protoc. 2017, 12, 865–880, doi: 10.1038/nprot.2017.018.
22. Xu, Z.; Li, E.; Guo, Z.; Yu, R.; Hao, H.; Xu, Y.; Sun, Z.; Li, X.; Lyu, J.; Wang, Q. Design and construction of a multi-organ microfluidic chip mimicking the in vivo microenvironment of lung cancer metastasis. ACS Appl. Mater Interfaces. 2016, 8, 25840–25847, doi: 10.1021/acsami.6b08746.
23. Nishiguchi, A.; Matsusaki, M.; Kano, M.R.; Nishihara, H.; Okano, D.; Asano, Y.; Shimoda, H.; Kishimoto, S.; Iwai, S.; Akashi, M. In vitro 3D blood/lymph-vascularized human stromal tissues for preclinical assays of cancer metastasis. Biomaterials 2018, 179, 144–155, doi: 10.1016/j.biomaterials.2018.06.019.
24. Bersini, S.; Moretti, M. 3D functional and perfusable microvascular networks for organotypic microfluidic models. J. Mater. Sci. Mater. Med. 2015, 26, 180, doi: 10.1007/s10856-015-5520-5.
25. Mathivanan, S.; Ji, H.; Simpson, R.J. Exosomes: extracellular organelles important in intercellular communication. J. Proteomics. 2010, 73, 1907–1920, doi: 10.1016/j.jprot.2010.06.006.
26. Ludwig, A.K.; Giebel, B. Exosomes: small vesicles participating in intercellular communication. Int. J. Biochem. Cell Biol. 2012, 44, 11–15, doi: 10.1016/j.biocel.2011.10.005.
27. Meldolesi, J. Exosomes and ectosomes in intercellular communication. Curr. Biol. 2018, 28, R435–R444, doi: 10.1016/j.cub.2018.01.059.
28. Carolina, F.R.; Adem, B.; Silva, M.; Melo, S.A. The biology of cancer exosomes: insights and new perspectives. Cancer Res. 2017, 77, 6480–6488, doi: 10.1158/0008-5472.CAN-17-0994.
29. Morikawa, K.; Walker, S.M.; Nakajimam. M.; Pathak, S.; Jessup, J.M.; Fidler, I.J. Influence of organ environment on the growth, selection, and metastasis of human colon carcinoma cells in nude mice. Cancer Res. 1988, 48, 6863–6871.
30. Nanes, B.A.; Grimsley-Myers, C.M.; Cadwell, C.M.; Robinson, B.S.; Lowery, A.M.; Vincent, P.A.; Mosunjac, M.; Früh, K.; Kowalczyk, A.P. p120-catenin regulates VE-cadherin endocytosis and degradation induced by the Kaposi sarcoma-associated ubiquitin ligase K5. Mol. Biol. Cell 2017, 28, 30–40, doi: 10.1091/mbc.E16- 06-0459.
31. Garrett, J.P.; Lowery, A.M.; Adam, A.P.; Kowalczyk, A.P.; Vincent, P.A. Regulation of endothelial barrier function by p120-catenin·VE-cadherin interaction. Mol. Biol. Cell 2017, 28, 85–97, doi: 10.1091/mbc.E16-08- 0616.
32. Arnold, M.; Sierra, M.S.; Laversanne, M.; Soerjomataram, I.; Jemal, A.; Bray, F. Global patterns and trends in colorectal cancer incidence and mortality. Gut 2017, 66, 683–691, doi: 10.1136/gutjnl-2015-310912.
33. Bray, F.; Ferlay, J.; Soerjomataram, I.; Siegel, R.L.; Torre, L.A.; Jemal, A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2018, 68, 394–424, doi: 10.3322/caac.21492.
34. Colvin, H.; Mizushima, T.; Eguchi, H.; Takiguchi, S.; Doki, Y.; Mori, M. Gastroenterological surgery in Japan: The past, the present and the future. Ann. Gastroenterol. Surg. 2017, 1, 5–10, doi: 10.1002/ags3.12008.
35. Yang, N.; Li, S.; Li, G.; Zhang, S.; Tang, X.; Ni, S.; Jian, X.; Xu, C.; Zhu, J.; Lu, M. The role of extracellular vesicles in mediating progression, metastasis and potential treatment of hepatocellular carcinoma. Oncotarget 2017, 8, 3683–3695, doi: 10.18632/oncotarget.12465.
36. Fang, J.H.; Zhang, Z.J.; Shang, L.R.; Luo, Y.W.; Lin, Y.F.; Yuan, Y.; Zhuang, S.M. Hepatoma cell-secreted exosomal microRNA-103 increases vascular permeability and promotes metastasis by targeting junction proteins. Hepatology 2018, 68, 1459–1475, doi: 10.1002/hep.29920.
37. Flores, P.A.; Rincón, D.G.; Ruiz-García, E.; Echavarria, R.; Marchat, L.A.; Álvarez-Sánchez, E.; López- Camarillo, C. Angiogenesis analysis by in vitro coculture assays in transwell chambers in ovarian cancer. Methods Mol. Biol. 2018, 1699, 179–186, doi: 10.1007/978-1-4939-7435-1_13.
38. Gorham, S.D.; Light, N.D.; Diamond, A.M.; Willins, M.J.; Bailey, A.J.; Wess, T.J.; Leslie, N.J. Effect of chemical modifications on the susceptibility of collagen to proteolysis. II. Dehydrothermal crosslinking. Int. J. Biol. Macromol. 1992, 14, 129–138, doi: 10.1016/s0141-8130(05)80002-9.